A B S T R A C T We have investigated the pathway of prothrombin activation in blood and plasma. By means of a rapid purification procedure involving chromatography on DEAE-cellulose and hydroxyapatite, we demonstrated that the major prothrombin fragment in serum is that representing the amino-terminal half of prothrombin (i.e. FL 2). The F1 2 isolated was characterized by its size, amino acid and antigenic compositions, amino-terminal residue, and the peptides (designated Fl and F2, respectively) it yielded upon hydrolysis by thrombin. Measurements by the isotope dilution technique showed that Fl 2 could account for the fate of at least 90% of the prothrombin originally present in plasma. By contrast, the serum concentration of the fragment representing the amino-terminal third of prothrombin (viz. F1) was <10% that of F1 -2. These results demonstrated that the major route of prothrombin conversion in blood or plasma involves the removal ofthe combined activation fragment (F1 *2) as a single peptide.
A B S T R A C T We have investigated the pathway of prothrombin activation in blood and plasma. By means of a rapid purification procedure involving chromatography on DEAE-cellulose and hydroxyapatite, we demonstrated that the major prothrombin fragment in serum is that representing the amino-terminal half of prothrombin (i.e. FL 2). The F1 2 isolated was characterized by its size, amino acid and antigenic compositions, amino-terminal residue, and the peptides (designated Fl and F2, respectively) it yielded upon hydrolysis by thrombin. Measurements by the isotope dilution technique showed that Fl 2 could account for the fate of at least 90% of the prothrombin originally present in plasma. By contrast, the serum concentration of the fragment representing the amino-terminal third of prothrombin (viz. F1) was <10% that of F1 -2. These results demonstrated that the major route of prothrombin conversion in blood or plasma involves the removal ofthe combined activation fragment (F1 *2) as a single peptide. INTRODUCTION Four different pathways have been proposed for the conversion of prothrombin to thrombin (Fig. 1) ; the ultimate products of each appear to be identical. The first to be proposed (Fig. 1, pathway 1 1 Fl is the peptide that arises from the amino-terminal region of prothrombin; F2 is the penultimate peptide; prethrombin 1 is prothrombin from which Fl has been removed; thrombin, followed by the scission of the remaining protein (viz., prethrombin 2) between the A and B chains so as to yield the disulfide-bridged thrombin molecule (1, 2) . More careful studies indicated that the initial event is the removal, by Factor Xa, of the activation fragment F1 -2 (which consists of the F1 and F2 moieties linked as a single peptide) in one step (3) (4) (5) . The prethrombin 2 formed in this step is then cleaved by Factor Xa to produce thrombin, which in turn catalyzes the cleavage of Fl 2 into Fl and F2 ( Fig. 1, pathway 2) .
Treatment of human (6) or bovine (7, 8) prothrombin with the procoagulant from the venom ofthe saw scaled viper Echis carinatus was shown to yield the aminoterminal peptide Fl, and a two-chain, disulfidebridged molecule with the molecular weight of prethrombin 1. The latter is composed of the B chain bridged to a peptide consisting of the F2 and A moieties. The activation scheme proposed on the basis of these results is summarized as pathway 3 (Fig. 1) .
Recent reports contain evidence that cleavage of prothrombin between the A and B moieties is the first step in activation, either by Factor Xa (9) or by E. carinatus procoagulant (10, 11) . According to this scheme (Fig. 1, pathway 4) , the initial product, which is composed of a long peptide (consisting of the Fl, F2, and A moieties) disulfide-bridged to the B chain, has proteolytic activity and therefore catalyzes the removal of Fl. The two chain product of this reaction also has proteolytic activity, as does thrombin itself, hence F2 can be cleaved off by any of these enzymes to yield thrombin as a final product. However, neither Esmon et al. (5) , who studied activation with Factor Xa, nor Franza et al. (6) The studies leading to the proposal of all the pathways shown in Fig. 1 were carried out in purified systems; few studies of the prothrombin conversion sequence have been done in plasma. The system used by Shapiro and Cooper (12) , which consisted of labeled prothrombin added to whole plasma, gave findings consistent with the removal of Fl *2 as a single entity, i.e., pathway 2. Immunologic studies also indicated the possibility of a single activation fragment during prothrombin conversion in plasma (13, 14) . On the other hand, Fass and Mann (15) (18) .
Absorption coefficients were determined by measuring the protein concentrations of dialyzed solutions in a BricePhoenix differential refractometer at 546 nm; a specific refractive increment of 0.186 ml/g was assumed. Portions of these solutions were then diluted, and the absorbances of the resulting solutions were measured at 280 nm in a Beckman 25 spectrophotometer.
Tritium labeling was done as described by Van Lenten and Ashwell (19) . The tritiated samples were stored at -70°C in acetate-buffered 0.15 M NaCl (pH 5.6) until used.
Thrombin was assayed as previously described (1) and standardized against U. S. Standard Thrombin (lot B-3). Prothrombin was measured in a two-stage test (20) with Difco (Difco Laboratories, Detroit, Mich.) two-stage reagent; 1 U ofprothrombin was defined as that amount yielding 1 U of thrombin. Factor X was measured by the method of Denson (21) with bovine Factor X-deficient plasma (Diagnostic Reagents, Ltd. Thames, Oxon, England).
RESULTS
Preparation of Fl -2. Pools of human plasma (4 liters each) were allowed to warm to ambient temperature (22°C) overnight. These were converted to serum by the addition of Russell's Viper venom and 1 M CaC12 (final concentrations 1 mg/liter and 10 mM, respectively). Clotting took place within 2.5 min after the addition of CaC12. The clot was wound, as it formed, on a polyethylene stirring rod. After 90 min, the residual prothrombin level was found to vary between 0 and 20% of that in the starting material; the residual Factor X level, between 10 and 30%. Heparin was then added (final concentration 7.5 mg/liter), the serum was diluted with 0.5 vol of distilled water, damp DE 1 Floc (50 g/ liter) was admixed, and the suspension was stirred for an additional 30 min. The adsorbent was packed into a glass column (8- Identification of Fl -2. When material prepared from serum in this manner was chromatographed, gradient elution yielded a curve with a number of small shoulders and one large peak (Fig. 2) . Gel electrophoresis of the fractions in sodium dodecyl sulfate showed the presence of several minor components of high molecular weight and a minor band which migrated at a rate similar to that of Fl. Densitometry of the stained gels showed that the major component, which migrated at a rate close to that of thrombin, comprised more than 90% of the sample. Incubation of this component (i.e. fractions from the major chromatographic peak- Fig. 2 ) with thrombin produced two components which were electrophoretically indistinguishable from Fl and F2, respectively, showing that this component was FL 2 (see below). On the other hand, if plasma rather than serum was fractionated by this procedure, the material eluted from hydroxyapatite at this position, i.e. at an elution volume of -400 ml, was a virtually homogeneous preparation of prothrombin (.95% by gel electrophoresis). Amino-terminal analysis of the Fl *2 preparation .showed alanine to be the major terminus, though a small amount of threonine was also present. When dansylation of the material was followed by gel electrophoresis, elution of the major band, and subsequent amino-terminal analysis, only dansyl alanine was found. Amino acid analysis was carried out after further purification of Fl 2 by exclusion chromatography on Sephadex G-200 (equilibrated and developed with 0.2 M NH4HCO3) to remove the high molecular weight contaminants (cf. Fig. 2 ). There was close agreement between the composition of the isolated material and the sum of the amino acid contents of Fl and F2 derived from human prothrombin3 (Table I) ; moreover, the composition was similar to that of bovine F1I 2 (22) .
Additional proof of the identity of Fl Sensitivity of Fl *2 to thrombin. The rate of digestion of the isolated Fl 2 by thrombin was determined by gel electrophoresis (Fig. 4) Slice number FIGURE 5 Gel electrophoresis of a tritium-labeled Fl 2 preparation. After electrophoresis, the gels were sliced into 1.2-mm segments. These were dissolved in H202 and the radioactivity was measured in a scintillation counter. As depicted, the anode is at the right; slice 1 thus corresponds to material located between the origin and a plane 1 CaCl2 at the concentrations used in the present experi-100 75 ments began within 2 min but exhibited only a gradual 50 37.5
increase. After 11 min, the level of thrombin activity in the blood system fell precipitously; by 15 min it had nearly returned to the base line (Fig. 6) . Similarly, after 15 proteins with 0.2 M potassium phosphate buffer, pH all prothrombin is 6.8, the column was washed with 0.7 M potassium hat Fl 2 represents phosphate buffer, also pH 6.8, and the fractions obtained during this final purification step were pooled (cf. Fig. 2 ). (These procedures were completed within Generation of Prothrombin Fragments during Clotting2 h of drawing the blood.) Two 5-ml portions of this pool were treated with diisopropylphosphorofluoridate (final concentration 1 mM) and concentrated 10-fold with a Minicon B15 filter (Amicon Corp., Scientific Sys. Div., Lexington, Mass.). One of these was then incubated with thrombin (final concentration 1.0 U/ml) for 2 h at 22°C. Gel electrophoresis of the material isolated from fresh serum revealed a major band migrating as F1 * 2 but no appreciable FL or F2 (Fig. 7, gel A) . Upon treatment with thrombin this band almost completely disappeared, and a new band migrating as Fl was seen (Fig. 7, gel B) . When the protein isolated from serum (i.e. not treated with thrombin) was tested by immunodiffusion against rabbit antihuman Fl, it gave a reaction of identity with Fl. However, when it was allowed to diffuse against rabbit antihuman prothrombin, it exhibited only partial identity with prothrombin (cf. Fig. 3 ).
DISCUSSION
The objective ofthe present study was to determine the pathway of prothrombin activation in whole blood and plasma. The approach used, i.e. isolation and quantitation of the fragments generated during clotting, was based on the following assumptions. If the conversion of plasma prothrombin to thrombin proceeds by the sequential removal of Fl and F2 (Fig. 1, pathway (Fig. 1, pathway 1) , and (c) cleavage of prethrombin 1 to two-chain prethrombin 1 (Fig. 1, pathway 3) . If, on the other hand, the major prothrombin fragment in serum were F1 * 2, it would indicate that the first step in prothrombin activation is the removal ofthis fragment as a single peptide (Fig. 1, pathway 2) . In this case, the relative importance of prothrombin cleavage to Fl plus prethrombin 1 could be assessed by comparing the amounts of F1 and F1 2 present in serum.5 A low ratio of F1 to FL *2 concentration would indicate that the Fl removal step has little quantitative significance, and hence that it cannot seriously be considered as a control mechanism in clotting.
Russell's Viper venom was chosen to induce the clotting of blood bank plasma so as to initiate activation at a late stage in the coagulation scheme (i.e. a Factor Xa-dependent step-see Fig. 1 ) and to ensure adequate prothrombin consumption. Under the conditions chosen, the majority of prothrombin and Factor X 5Because thrombin, once formed, can catalyze the cleavage of Fl 2 to Fl plus F2, the level of Fl in serum would indicate the maximum possible importance of Fl removal.
Vi AR KER\-FIGuRE 7 Gel electrophoresis of Fl 2 isolated after the clotting of whole blood. As depicted, the anode is at the bottom. Gel A is the protein isolated from serum after clotting (see text) and gel B is the preparation shown in gel A after treatment with thrombin (1 U/ml for 2 h). The F2 band is not visible in the photograph of gel B, but a faint band migrating as F2 could be seen on the original gel.
The small amount of FL *2 available from whole blood precluded the use of a higher load.
was consumed within 15 min after the addition of Ca2+. Residual prothrombin activity after 90 min was 0-20% of that in the starting plasma. (The blood bank plasma used contained 120 U of prothrombin/ml as opposed to 160 U/ml fresh plasma.)
The preparations obtained by the method described above routinely contained more than 90% Fl 2. The major contaminants were Fl and several high molecular weight components. It was impossible to ascertain whether the Fl was formed in the serum or during fractionation. However, if heparin was not added to the serum before fractionation, the material eluted from hydroxyapatite rapidly degraded to Fl and F2.
Identification of the isolated substance as the combined activation peptide, Fl *2, was based on its molecular size (Fig. 7) , amino acid (Table I ) and antigenic (Fig. 3) compositions, amino-terminal residue, and ability to yield Fl and F2 upon hydrolysis by thrombin. The mol wt of human F1 *2 calculated from composition data was -34,500 (Table I) . It is there-
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Aronson, Stevan, Ball, Franza, and Finlayson W--fore reasonable that this fragment migrated at approximately the same rate as human thrombin (36,500 mol wt) in the electrophoretic system (Fig. 7) , as is the assumption that it represented half of the prothrombin molecule (Table II) . The amino-terminus of F1 2 was found to be alanine, which is the amino-terminus of prothrombin. Furthermore, the amino acid composition was shown to approximate the sum of the amino acid contents of Fl and F2 isolated after the activation of purified prothrombin (Table I) . Although the amino acid composition is similar to that reported for bovine F1 2 (22) , there are differences in the serine, threonine, arginine, histidine, proline, and tyrosine contents. However, the sum of the hydroxyamino acids and that of the basic amino acids is similar for bovine and human F1 2. The observation that antiserum to F1 indicated antigenic identity of F1, F1 * 2, and prothrombin, whereas these antigens exhibited spurring when reacted with anti-human prothrombin (Fig. 3) , is consistent with the fact that all three contain the Fl determinants, but F1 2 lacks the prethrombin 2 moiety and Fl lacks the F2 region as well (Fig. 1) . Finally, a salient feature of the isolated FL 2 was its rapid hydrolysis by thrombin (Fig. 4 and [4] ) to fragments which were electrophoretically indistinguishable from Fl and F2. The methods for quantitating FL 2 in serum were both based on the assumption that this fragment, when labeled with tritium, would behave identically to the native peptide during fractionation. Although the yield from DEAE-cellulose (30%) was low, it was consistent with that of prothrombin treated in the same manner (23-37%). Likewise, the recovery from hydroxyapatite (50%) was similar to that for human prothrombin. Both the mass recovery and the isotope dilution experiments indicated that the Fl 2 pathway must be the major route followed during the activation of prothrombin in whole blood or plasma and, in fact, that it can account for the fate of at least 90% of the prothrombin originally present (Table II) .
Even though the isolation from serum obtained by the spontaneous clotting of whole blood showed that the FL 2 pathway is followed in the latter medium, the pattern of thrombin generation observed was quantitatively different from that in plasma clotted with Russell's Viper venom and CaCl2 (Fig. 6) . However, despite this difference in the generation profiles, there should have been sufficient thrombin generated in either system to catalyze the cleavage of a substantial portion of the Fl 2 (cf. Fig. 4 ). Several factors may contribute to the stability of this peptide in blood or plasma. First, the fact that the cleavage of F1 *2 in the purified system (Fig. 4) was first order at a substrate concentration of -50 ,uM suggests that the Km is at least 0.5 mM. The maximum concentration of Fl 2 in serum, -2 ,uM is far below this and would permit only a low rate of hydrolysis. Second, the availability of competing substrates may have diminished thrombin activity toward Fl *2 still further. Finally, the susceptibility of F1 2 to hydrolysis could be different in the purified and the natural milieu.
The removal of the amino-terminal fragment, Fl, from prothrombin has been proposed as a control mechanism in coagulation. Though Stenn and Blout (3) have found evidence that this may be a minor pathway catalyzed by Factor Xa, most data obtained by studying purified systems indicate that the cleavage of Fl from prothrombin is predominantly due to thrombin (3, 4, 22, 23) . However, removal of Fl from prothrombin by thrombin is slow compared with the hydrolysis of FL 2 by this enzyme in purified systems (cf. [6] and Fig. 4) . Thus the presence of Fl *2 in serum is, per se, a strong argument against the Fl pathway having a significant role in the control of coagulation in neat plasma. This conclusion was confirmed by the demonstration (Table II) that the F1 -2 pathway is the major route followed during the clotting of plasma. The presence of Fl 2 in serum derived from fresh whole blood suggests that it is true for all circumstances in which thrombin is rapidly inactivated. Only in systems lac'king sufficient thrombin inhibition, in particular in concentrated solutions of purified clotting factors (22, 24) , can the removal of Fl from prothrombin by thrombin become significant.
The foregoing results support the kinetic analysis of Esmon et al. (5) , even in whole blood. The noncovalent linkage of the Fl 2 and prethrombin 2 moieties of prothrombin (cf. Fig. 1 ) is necessary for rapid conversion to thrombin. Inasmuch as prethrombin 2 is measured as prothrombin by the two-stage assay, the inability ofthis procedure to detect prothrombin in serum implies that prothrombin is totally converted to thrombin and does not remain as prethrombin 2. This is consistent with the finding that prethrombin 2, which was activated slowly by Taipan snake venom in the presence of Ca2+ and phospholipid, activated very rapidly in the presence of Fl 2 or serum (25) . In light of these results, any modulation of prothrombin activation in the presence of adequate levels of Factor Xa would seem to occur through (a) inhibition of Factor Xa and (b) activation and inactivation of Factor V, rather than by removal of the Fl fragment.
